Filing Details

Accession Number:
0001432453-15-000019
Form Type:
5
Zero Holdings:
No
Publication Time:
2015-03-10 15:30:28
Reporting Period:
2014-01-31
Filing Date:
2015-03-10
Accepted Time:
2015-03-10 15:30:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1464165 Neurokine Pharmaceuticals Inc. NEUKF Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1464116 Ahmad Doroudian 1275 West 6Th Avenue
Vancouver A1 V6H 1A6
Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2013-09-24 35,000,000 $0.00 37,469,784 No 5 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 2,469,784 Direct
Common Shares 2,000,000 Indirect owned by spouse
Common Shares 2,000,000 Indirect owned by Kinwa Pharma International Company Ltd.
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Stock Options $0.01 2010-05-25 2015-05-25 800,000 800,000 Direct
Common Shares Warrants $0.01 2010-07-30 2015-07-29 500,000 500,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-05-25 800,000 800,000 Direct
2015-07-29 500,000 500,000 Direct
Footnotes
  1. Kinwa Pharma International Company Ltd. is a company over which Dr. Ahmad Doroudian and his spouse have shared voting and investment power.
  2. Acquisition of shares through settlement of debts (deemed price of $0.001)